StockStory.org on MSN
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported in Q3 CY2025, with sales up 20% year on year to $850.7 ...
StockStory.org on MSN
ARES Q3 Deep Dive: Diversified Fundraising and Broad-Based Deployment Drive Earnings Upside
Alternative asset manager Ares Management (NYSE:ARES) in Q3 CY2025, with sales up 35.7% year on year to $1.14 billion. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback